Bilateral blindness after uneventful brolucizumab injection for macular degeneration
Abstract Background We report a very severe case of bilateral panuveitis and ischemic vasculitis with possible perineural inflammation, which followed bilateral intravitreal brolucizumab administration in a patient with neovascular age-related macular degeneration (nAMD). Case presentation On Decemb...
Main Authors: | Ilan Barchichat, Michael Thiel, Oliver Job, Martin Schmid |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-022-02305-1 |
Similar Items
-
Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema
by: Takao Hirano, et al.
Published: (2023-03-01) -
Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
by: Ashwin Gupta, et al.
Published: (2022-01-01) -
Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration
by: Sara J. Haug, et al.
Published: (2020-06-01) -
Efficacy, Safety, and Durability of Brolucizumab: An 8-Month Post-Marketing Surveillance Analysis
by: Saba NJ, et al.
Published: (2023-09-01) -
Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
by: Chakraborty D, et al.
Published: (2021-09-01)